Associated Papers
Successful treatment of generalized inflammatory linear verrucous epidermal naevus with a somatic mutation in KRT10 with crisaborole 2% ointment.
Li Z et al.
Clinical and Experimental Dermatology, 2025
Clinical and Genetic Findings in Patients With Palmoplantar Keratoderma.
Gram SB et al.
Jama Dermatology, 2025
Clinical Characteristics of CARD14-Associated Papulosquamous Eruption and Evaluation of Therapeutic Efficacy of Secukinumab.
Zhao X et al.
Journal of Inflammation Research, 2025
Targeting IL-1 controls refractory pityriasis rubra pilaris.
Schmauch E et al.
Science Advances, 2024
Effect of secukinumab on inflammatory linear verrucous epidermal naevus with a somatic mutation in CARD14.
Zhao X et al.
Clinical and Experimental Dermatology, 2024
Case report: Successful treatment with biologics in a pediatric patient with a severe inflammatory skin disease and novel CARD14 mutation.
Niedźwiedź M et al.
Frontiers in Medicine, 2024
Association of CARD14 Single-Nucleotide Polymorphisms with Psoriasis.
Suleman S et al.
International Journal of Molecular Sciences, 2022
Identification of a pathogenic CARD14 mutation in a 70-year-old woman with pityriasis rubra pilaris: when genetic diagnosis influences choice of treatment strategy.
Nielsen RM et al.
Bmj Case Reports, 2021
CARD14-mutations in pityriasis rubra pilaris and therapeutic response to ustekinumab - a hypothesis.
Volc-Platzer B
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : Jddg, 2020
Regulation and dysregulation of CARD14 signalling and its physiological consequences in inflammatory skin disease.
Mellett M
Cellular Immunology, 2020
CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris.
Craiglow BG et al.
Journal of the American Academy of Dermatology, 2018
CARD14/CARMA2 Signaling and its Role in Inflammatory Skin Disorders.
Zotti T et al.
Frontiers in Immunology, 2018
Clinical and Genetic Heterogeneity of CARD14 Mutations in Psoriatic Skin Disease.
Israel L et al.
Frontiers in Immunology, 2018
CARD14-Mediated Activation of Paracaspase MALT1 in Keratinocytes: Implications for Psoriasis.
Van Nuffel E et al.
The Journal of Investigative Dermatology, 2017
Target-sequence Capture and High Throughput Sequencing Identify a De novo CARD14 Mutation in an Infant with Erythrodermic Pityriasis Rubra Pilaris.
Has C et al.
Acta Dermato-venereologica, 2016
iFish: predicting the pathogenicity of human nonsynonymous variants using gene-specific/family-specific attributes and classifiers.
Wang M et al.
Scientific Reports, 2016
CARD14 Glu138 mutation in familial pityriasis rubra pilaris does not warrant differentiation from familial psoriasis.
Inoue N et al.
The Journal of Dermatology, 2016
[Hereditary palmoplantar keratoderma - a focus on clinical and molecular genetic aspects].
Kamaleswaran S et al.
Ugeskrift for Laeger, 2014